{
  "version": "2.0",
  "last_updated": "2026-01-28",
  "description": "Validated biomarker triplets for FRANCIS survival stratification",
  
  "validated_triplets": {
    "GBM": {
      "cancer_name": "Glioblastoma",
      "embryonic_origin": "Neuroectoderm",
      "markers": ["CXCL13", "SOX2", "LGALS1"],
      "validation": {
        "n_patients": 134,
        "n_deaths": 102,
        "p_value": 1.6e-5,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "SOX2": "Cancer stem cell marker - self-renewal and treatment resistance",
        "LGALS1": "Galectin-1 - CNS immunosuppression via T-cell apoptosis"
      }
    },
    "SKCM": {
      "cancer_name": "Cutaneous Melanoma",
      "embryonic_origin": "Neural Crest",
      "markers": ["FABP4", "CXCL13", "CD8A"],
      "validation": {
        "n_patients": 276,
        "n_deaths": 157,
        "p_value": 0.0007,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "FABP4": "Lipid metabolism - melanoma metabolic reprogramming",
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "CD8A": "Cytotoxic T-cell infiltration - immunotherapy responsiveness"
      }
    },
    "LUAD": {
      "cancer_name": "Lung Adenocarcinoma",
      "embryonic_origin": "Epithelial",
      "markers": ["CXCL13", "GAPDH", "KRAS"],
      "validation": {
        "n_patients": 392,
        "n_deaths": 135,
        "p_value": 0.0019,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "GAPDH": "Glycolysis - Warburg effect indicator",
        "KRAS": "Oncogenic driver - metabolic reprogramming"
      }
    },
    "COADREAD": {
      "cancer_name": "Colorectal Adenocarcinoma",
      "embryonic_origin": "Epithelial",
      "markers": ["CXCL13", "TOP2A", "KRAS"],
      "validation": {
        "n_patients": 402,
        "n_deaths": 84,
        "p_value": 0.0046,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "TOP2A": "Proliferation - chemotherapy sensitivity",
        "KRAS": "RAS pathway - treatment response predictor"
      }
    },
    "BRCA": {
      "cancer_name": "Breast Invasive Carcinoma",
      "embryonic_origin": "Epithelial",
      "markers": ["CXCL13", "ARG1", "CD8A"],
      "validation": {
        "n_patients": 790,
        "n_deaths": 114,
        "p_value": 0.0053,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "ARG1": "MDSC activity - arginine depletion immunosuppression",
        "CD8A": "Cytotoxic T-cell infiltration density"
      }
    },
    "SARC": {
      "cancer_name": "Sarcoma",
      "embryonic_origin": "Mesenchymal",
      "markers": ["CXCL13", "CD8A", "PDCD1"],
      "validation": {
        "n_patients": 169,
        "n_deaths": 71,
        "p_value": 0.0117,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation",
        "CD8A": "Cytotoxic T-cell infiltration",
        "PDCD1": "PD-1 - T-cell exhaustion and checkpoint engagement"
      }
    },
    "OV": {
      "cancer_name": "Ovarian Serous Cystadenocarcinoma",
      "embryonic_origin": "Epithelial",
      "markers": ["LDHA", "MKI67", "CXCL13"],
      "validation": {
        "n_patients": 252,
        "n_deaths": 149,
        "p_value": 0.0152,
        "source": "TCGA PanCancer Atlas"
      },
      "rationale": {
        "LDHA": "Glycolysis - Warburg effect",
        "MKI67": "Ki-67 proliferation index",
        "CXCL13": "Universal immune anchor - B-cell recruitment for TLS formation"
      }
    }
  },
  
  "universal_marker": {
    "gene": "CXCL13",
    "full_name": "C-X-C Motif Chemokine Ligand 13",
    "aliases": ["BLC", "BCA-1"],
    "chromosome": "4q21",
    "receptor": "CXCR5",
    "presence_in_triplets": "7/7 (100%)",
    "mechanism_solid_tumors": "Recruits B-lymphocytes that form tertiary lymphoid structures (TLS) within tumor microenvironment, enabling anti-tumor immune response",
    "note": "Mechanism differs from B-cell malignancies where CXCL13 promotes autocrine tumor survival"
  },
  
  "intermediate_instability_regime": {
    "aneuploidy_low": 5,
    "aneuploidy_high": 25,
    "description": "Genomic instability regime where tumors occupy metastable state with impaired immune surveillance",
    "phenomenon": "Intermediate Instability Trap - paradoxically worse survival than both low and high instability"
  },
  
  "validation_totals": {
    "total_patients": 2415,
    "total_deaths": 812,
    "cancer_types": 7,
    "embryonic_lineages": 3,
    "all_p_less_than": 0.05,
    "analysis_method": "Log-rank survival analysis with median DII split"
  },
  
  "excluded_cancers": {
    "DLBC": {
      "reason": "B-cell lymphoma - CXCL13 mechanism is opposite (autocrine survival signaling)",
      "note": "In B-cell malignancies, CXCL13 produced by malignant cells promotes tumor survival"
    }
  },
  
  "marker_panels": {
    "immune_checkpoint": ["CD274", "PDCD1", "CTLA4", "LAG3", "HAVCR2", "TIGIT"],
    "metabolic": ["LDHA", "GAPDH", "HIF1A", "PKM", "SLC2A1", "FABP4"],
    "immune_infiltration": ["CD8A", "CD4", "FOXP3", "CXCL13", "CD19", "MS4A1"],
    "proliferation": ["MKI67", "TOP2A", "PCNA", "MCM2", "CDK1"],
    "stemness": ["SOX2", "NANOG", "POU5F1", "PROM1", "ALDH1A1"],
    "immunosuppression": ["ARG1", "LGALS1", "IDO1", "TGFB1", "IL10"]
  },
  
  "patents": [
    {
      "application_number": "63/968,064",
      "title": "Systems and Methods for Predicting and Controlling Physiological Collapse Using Dynamical Biomarker Indices",
      "filed": "2026-01-26"
    },
    {
      "application_number": "63/970,059",
      "title": "Methods, Systems, and Kits for Pan-Cancer Survival Stratification Using CXCL13-Anchored Biomarker Triplets Within Intermediate Genomic Instability Regimes",
      "filed": "2026-01-28"
    }
  ]
}
